Literature DB >> 1130377

Variability of serum gastrin levels in Zollinger-Ellison syndrome. Studies with two antisera to gastrin.

K J Ivey, J Hansky.   

Abstract

A patient with recurrent peptic ulceration and presumed Zollinger-Ellison syndrome whose serum gastrin concentration varied widely is reported. Two antisera, one directed predominantly against nonsulfated gastrin and the other measuring both sulfated and nonsulfated gastrin, showed that in addition to wide variation in gastrin levels, this patient secreted his gastrin predominantly in the sulfated G34 form. The possibility of variable serum gastrin levels, which may reflect either spontaneous vaiation in gastrin output from Z-E tumors or differing specificity of the antiserum utilized in the immunoassay, may be of importance in the diagnosis and management of patients with the Zollinger-Ellison syndrome. Because of gastrin heterogeneity in the Z-E syndrome, this study reinforces the concept that a broad spectrum antibody, detecting all gastrin components should be routinely used in detection of patients suspected of having the Z-E syndrome.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1130377     DOI: 10.1007/bf01074935

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN: 0002-9211


  13 in total

1.  SPONTANEOUS REMISSION OF ZOLLINGER-ELLISON SYNDROME.

Authors:  C S MELNYK; W W KRIPPAEHNE; J A BENSON; J E DUNPHY
Journal:  Arch Intern Med       Date:  1965-01

2.  Zollinger-Ellison syndrome treated with poldine methyl methosulphate.

Authors:  R S LAWRIE; A W WILLIAMSON; J N HUNT
Journal:  Lancet       Date:  1962-05-12       Impact factor: 79.321

3.  Clinical role of serum gastrin measurements in the Zollinger-Ellison syndrome.

Authors:  J C Thompson; D D Reeder; H H Bunchman
Journal:  Am J Surg       Date:  1972-08       Impact factor: 2.565

Review 4.  Progress report. Diagnosis of insulinoma.

Authors:  V Marks
Journal:  Gut       Date:  1971-10       Impact factor: 23.059

5.  Variability of gastric secretion in patients with and without the Zollinger-Ellison syndrome.

Authors:  D H Winship; E H Ellison
Journal:  Lancet       Date:  1967-05-27       Impact factor: 79.321

6.  Studies with two gastrin antisera of different specificity for gastrins I and II.

Authors:  J Hansky; C Soveny; M G Korman
Journal:  Digestion       Date:  1974       Impact factor: 3.216

7.  Pancreatic function in patients with the Zollinger-Ellison syndrome. Observations concerning acid-bicarbonate secretion ratios.

Authors:  D A Dreiling; A Greenstein
Journal:  Med Chir Dig       Date:  1972

8.  Ionic movement across the gastric mucosa of man: reproducibility and effect of intravenous atropine.

Authors:  K J Ivey; J A Clifton
Journal:  J Lab Clin Med       Date:  1971-11

9.  Pancreatic hypersecretion in the Zollinger-Ellison syndrome. Case report.

Authors:  W P Dyck
Journal:  Gastroenterology       Date:  1971-01       Impact factor: 22.682

10.  Gel filtration studies on immunoreactive gastrin in serum from Zollinger-Ellison patients.

Authors:  J F Rehfeld; F Stadil
Journal:  Gut       Date:  1973-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.